Envío a todo Costa Rica por solo ₡1490 

Enviar a
Costa Rica
0
  • argentina
  • chile
  • colombia
  • españa
  • méxico
  • perú
  • estados unidos
  • internacional

Selecciona tu país

América

Europa

Resto del mundo

portada Management of Chemotherapy-Induced Nausea and Vomiting: New Agents and new Uses of Current Agents (en Inglés)
Formato
Libro Físico
Editorial
Año
2016
Idioma
Inglés
N° páginas
181
Encuadernación
Tapa Dura
ISBN13
9783319270142
N° edición
1
Categorías

Management of Chemotherapy-Induced Nausea and Vomiting: New Agents and new Uses of Current Agents (en Inglés)

Libro Nuevo Importado
Envío: 14 a 17 días háb.
₡ 29.622
Costos de importación y 13% IVA incluídos en el precio ✅
Libro Nuevo

Quedan más de 100 unidades

₡ 29.622
Llega entre el 29 Jun y el 06 Jul a Costa Rica. Seleccionar ubicación

Reseña del libro "Management of Chemotherapy-Induced Nausea and Vomiting: New Agents and new Uses of Current Agents (en Inglés)"

This book provides a comprehensive review of new agents, a detailed description of new uses of current agents, and an integration of the available agents in clinical practice. A description of a detailed clinical approach provides clinical practitioners with the most up-to-date recommendations for the prevention and treatment of chemotherapy-induced nausea and vomiting (CINV) in various clinical settings.CINV is one of the most feared treatment related toxicities. Patient surveys for the past thirty years consistently demonstrate patients’ perception of deterioration in quality of life due to chemotherapy treatments. The introduction of the antiemetics, serotonin 5-HT3 receptor antagonists and the neurokinin-1 receptor antagonists, have improved the control of chemotherapy-induced emesis, but the treatment of chemotherapy-induced nausea remains a significant clinical problem. Patients continue to have quality of life issues which prevent normal functioning during active treatment. New agents such as the second generation 5-HT3 receptor antagonist palonosetron and the new neuroknin-1 receptor antagonists rolapitant and netupitant are being introduced into clinical practice, and it is anticipated that these new agents will improve the control of CINV. Agents such as olanzapine (a FDA approved anti-psychotic), gabapentin (a FDA approved neuroleptic), and ginger (a food additive), which have been used primarily for other indications, are now being tested as potential, effective antiemetics. This work represents the first available comprehensive summary that details all new antiemetic agents and, particularly, their clinical role in treating patients; an important reference for practitioners seeking to improve the quality of life of patients undergoing chemotherapy.

Opiniones del libro

Preguntas frecuentes sobre el libro

Todos los libros de nuestro catálogo son Originales.
El libro está escrito en Inglés.
La encuadernación de esta edición es Tapa Dura.

Preguntas y respuestas sobre el libro

¿Tienes una pregunta sobre el libro? Inicia sesión para poder agregar tu propia pregunta.

Opiniones sobre Buscalibre

Ver más opiniones de clientes